Nextage Therapeutics Ltd (TASE: NXTG)
Health Care · Biotechnology · IL
₪0.37
-3.95% today · -53.8% 1Y
Nextage Therapeutics Ltd (TASE: NXTG) operates in the Biotechnology industry within the Health Care sector. The company is valued at $9.54M and employs 18 people.
Over the last twelve months the share price has lost 53.8%, trading between 0.06 and 0.99.
Tweenvest scores Nextage Therapeutics Ltd across four factors: quality 40/100, value 59/100. Its strongest factor is value.
NXTG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.54M
- Revenue (TTM)
- $843.21K
- P/E
- —
- EPS
- -0.22
- Dividend yield
- —
- Beta (5Y)
- 0.14
- 52-week high
- ₪0.99
- 52-week low
- ₪0.06
- Avg volume (3M)
- —
- Shares outstanding
- 81.06M
- Employees
- 18
- Next earnings
- —
About Nextage Therapeutics Ltd
Nextage Therapeutics Ltd, a pharmaceutical company, develops cannabinoid-based products in Israel and internationally. The company was incorporated in 1982 and is based in Ness Ziona, Israel.
- ISIN
- IL0004330119
- Founded
- 1982
- Listed since
- Aug 12, 2002
- Exchange
- The Tel-Aviv Stock Exchange
- Currency
- ILS
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Ensysce Biosciences, Inc.NasdaqCM: ENSC | $10.08M | $0.52 | -1.65% |
| AtonENXTPA: ALTAO | $10.02M | €0.01 | -12.90% |
| China Regenerative Medicine International LimitedSEHK: 8158 | $9.89M | HK$0.26 | -17.74% |
| Theriva Biologics, Inc.NYSEAM: TOVX | $9.54M | $0.21 | -4.19% |
| Solvonis Therapeutics plcLSE: SVNS | $9.53M | £0.00 | -4.76% |
| CRISM Therapeutics CorporationAIM: CRTX | $9.51M | £0.09 | -2.70% |
| PeopleBio, Inc.KOSDAQ: A304840 | $9.47M | ₩— | — |
| Lisata Therapeutics, Inc.NasdaqCM: LSTA | $9.28M | $1.03 | -2.83% |
Figures last refreshed Oct 18, 2026.